Citadel Advisors
ENZ

Citadel Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Citadel Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,300
Closed -$13.1K – 15902
2024
Q4 		$13.1K Buy
18,300
+16,000
+696% +$16.6K ﹤0.01% 13464
2024
Q3 		$2.58K Sell
2,300
-31,700
-93% -$35.5K ﹤0.01% 13734
2024
Q2 		$37.1K Buy
+34,000
New +$38.3K ﹤0.01% 12063
2023
Q4 		– Sell
-41,100
Closed -$57.5K – 15439
2023
Q3 		$57.5K Sell
41,100
-2,100
-5% -$3.17K ﹤0.01% 11585
2023
Q2 		$79.5K Sell
43,200
-3,600
-8% -$8.33K ﹤0.01% 11259
2023
Q1 		$114K Buy
46,800
+21,200
+83% +$31.5K ﹤0.01% 11074
2022
Q4 		$36.6K Buy
25,600
+14,200
+125% +$27.7K ﹤0.01% 12516
2022
Q3 		$25K Buy
+11,400
New +$27.5K ﹤0.01% 11988
2021
Q1 		– Sell
-17,100
Closed -$43K – 13819
2020
Q4 		$43K Buy
17,100
+6,800
+66% +$14.8K ﹤0.01% 10621
2020
Q3 		$22K Buy
+10,300
New +$24.5K ﹤0.01% 9840
2017
Q4 		– Sell
-17,900
Closed -$187K – 8527
2017
Q3 		$187K Sell
17,900
-100
-0.6% -$1.11K ﹤0.01% 6749
2017
Q2 		$199K Buy
+18,000
New +$168K ﹤0.01% 6574
2016
Q3 		– Sell
-11,800
Closed -$70K – 7884
2016
Q2 		$70K Buy
+11,800
New +$65.5K ﹤0.01% 6323
2016
Q1 		– Sell
-11,400
Closed -$51K – 8165
2015
Q4 		$51K Buy
+11,400
New +$48.1K ﹤0.01% 7299
2015
Q3 		– Sell
-5,200
Closed -$16K – 9297
2015
Q2 		$16K Buy
5,200
+4,000
+333% +$11.2K ﹤0.01% 8266
2015
Q1 		$4K Sell
1,200
-500
-29% -$1.64K ﹤0.01% 8361
2014
Q4 		$8K Buy
1,700
+1,200
+240% +$5.72K ﹤0.01% 8184
2014
Q3 		$3K Buy
500
+100
+25% +$534 ﹤0.01% 7971
2014
Q2 		$2K Buy
+400
New +$1.73K ﹤0.01% 7838

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Citadel Advisors's ENZ Position: Q2 2025 in Review

Citadel Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 210,877 shares — an estimated $78K sold.

Citadel Advisors first reported a position in ENZ in Q2 2013 and held it in 44 quarters. The position peaked at $958K in Q4 2014. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Citadel Advisors reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 210,877 Enzo Biochem, Inc. shares in Q2 2025, an estimated $78K.
  • Citadel Advisors first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 44 quarters.
  • Citadel Advisors's Enzo Biochem, Inc. position peaked at $958K in Q4 2014.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.